Related Experiment Video

Updated: Oct 29, 2025

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.6K

Therapeutic Response of Soft Tissue Sarcoma With Novel SS18-POU5F1 Fusion: A Case Report

Zengjun Liu1,2, Hongtu Yuan3, Mingyong Han1

  • 1Tumor Research and Therapy Center, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Frontiers in Oncology
|July 12, 2021
PubMed

Insights

This study reports on a rare soft tissue sarcoma with an SS18-POU5F1 fusion gene. The tumor showed no response to systemic therapies but had a temporary response to radiotherapy.

Area of Science:

  • Oncology
  • Genetics
  • Sarcoma Research

Background:

  • A novel SS18-POU5F1 fusion gene has been identified in soft tissue sarcomas affecting adolescents and young adults.
  • Understanding the treatment response of this rare sarcoma subtype is crucial for clinical management.

Observation:

  • This report details the treatment response of an SS18-POU5F1 sarcoma patient to various therapies.
  • The patient received immune checkpoint inhibitors, angiogenesis inhibitors, chemotherapy, and radiotherapy.

Findings:

  • The SS18-POU5F1 sarcoma exhibited resistance to immune checkpoint inhibitors, angiogenesis inhibitors, and chemotherapy.
  • A rapid, significant, yet transient clinical response was observed following radiotherapy.

Implications:

  • Radiotherapy may offer a temporary therapeutic option for SS18-POU5F1 sarcomas.
  • Further research is necessary to understand the differential response to radiotherapy versus systemic therapies in this specific sarcoma subtype.
Keywords:
POU5F1SS18fusionsoft tissue sarcomatherapeutic response

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.8K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K